Pacific Biosciences of California Inc. sell Barclays PLC
Start price
14.04.26
/
50%
€1.28
Target price
14.04.27
€0.85
Performance (%)
-7.56%
Price
15:30
€1.19
Summary
This prediction is currently active. With a performance of -7.56%, the SELL prediction for Pacific Biosciences of California Inc. by Barclays_PLC is down slightly. This prediction currently runs until 14.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | -4.663% | -4.663% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Barclays_PLC for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (PACB) had its price target lowered by Barclays PLC from $1.50 to $1.00. They now have an "underweight" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by Barclays_PLC for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.18
11.05.26
11.05.26
€1.28
11.05.27
11.05.27
0.68%
15:30
15:30
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.30
06.03.26
06.03.26
€1.29
06.03.27
06.03.27
-8.87%
15:30
15:30